NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Acorda Therapeutics (NQ: ACOR)
1.625 USD  +0.105 (+6.91%)
Streaming Delayed Price  /  Updated: 1:01 PM EST, Nov 21, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 947,171
Open 1.550
Bid (Size) 1.620 (8)
Ask (Size) 1.630 (21)
Prev. Close 1.520
Today's Range 1.490 - 1.650
52wk Range 1.490 - 21.13
Shares Outstanding 47,066,476
Dividend Yield N/A
Performance
YTD
-89.98%
-89.98%
1 Month
-31.72%
-31.72%
3 Month
-48.25%
-48.25%
6 Month
-85.19%
-85.19%
1 Year
-91.24%
-91.24%
Top News
More News
Acorda Therapeutics Announces Departure of President, International & General Counsel
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Jane Wasman, President, International & General Counsel, is resigning from the company effective at the end of this year. Ms. Wasman plans... Read More
from Business Wire News Releases
Acorda Provides Update for Third Quarter Ended September 30, 2019
Acorda Therapeutics, Inc. (NASDAQ: ACOR) provided a financial update for the quarter ended September 30, 2019. Read More
from Business Wire News Releases
More News
Read More
Acorda Therapeutics Implements Corporate Restructuring, Provides Third Quarter 2019 Update
from Business Wire News Releases
Biotech Stock On The Radar: Alkermes At A Crossroads
category BIIB , AZN , General , and 10 more.
from Benzinga
Acorda Launches New Tool for People with Parkinson’s to Improve Communication About OFF Periods
from Business Wire News Releases
Acorda Third Quarter 2019 Update: Webcast/Conference Call Scheduled for November 4, 2019
from Business Wire News Releases
UPDATE 2-U.S. Supreme Court opens new term, with an ill Justice Thomas absent
category companyNews
from Reuters: Company News
UPDATE 1-U.S. Supreme Court kicks off new term, with Justice Thomas absent
category companyNews
from Reuters: Company News
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon
category HEPA , PODD , REXN , and 79 more.
from Benzinga
Stocks That Hit 52-Week Lows On Wednesday
category ECDP , Industrials , ETRN , and 157 more.
from Benzinga
The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
category PFE , OCGN , HALO , and 65 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.